Neonatal vasopressin antagonist treatment facilitates adult copulatory behavior in female rats and increases hypothalamic vasopressin content.
This study confirms that i.c.v. administration of Arg-vasopressin (AVP, 20 ng) inhibits copulatory behavior in female rats (lordosis response, LR) and demonstrates that this inhibitory effect is blocked by the vasopressin antagonist (3-mercapto-3-methylbutyryl-Tyr-[Me])arginine vasopressin (dPTyr(Me)AVP, 20 ng, i.c.v.). The effects of neonatal AVP antagonist treatment on adult female copulatory behavior, hypothalamic content of AVP and AVP-like immunoreactive (AVP-ir) neurons were examined. dPTyr(Me)AVP was given to female rats 1 microgram/animal/day s.c. from day 1 through to day 7 (day 0 = day of birth). The females were ovariectomized as adults and sexual receptivity activated by submaximal doses of estradiol plus progesterone. The LR was significantly facilitated in the neonatally dPTyr(Me)AVP treated females who also showed a higher content and an increased number of AVP-ir neurons in the suprachiasmatic nucleus compared to saline controls. Functional, biochemical and immunocytochemical evidence is provided that neonatal exposure to an AVP antagonist induces persistent changes in central vasopressinergic neuronal mechanisms.